Skip to main content
Top
Published in: BMC Pediatrics 1/2023

Open Access 01-12-2023 | Leukodystrophy | Case report

Fatal leukodystrophy in Costello syndrome: a case report

Authors: Virgilio E. Failoc-Rojas, Piero A. Quiroz Ugaz, Dante A. Loconi León, Sandra Zeña-Ñañez

Published in: BMC Pediatrics | Issue 1/2023

Login to get access

Abstract

Background

Costello syndrome (CS) is a rare genetic condition characterized by dysregulation of the signaling pathway, phenotypic alteration due to fetal macrosomia or growth retardation, facial abnormalities, loose skin, cardiovascular abnormalities, and a variable degree of intellectual disability.

Case presentation

We describe the case of a 20-month-old male patient with fetal macrosomia and polyhydramnios, presenting psychomotor development delay and growth limitation during the first months of life. CS was diagnosed at four months of age after detecting a variant of the HRAS gene c.35G > C (p.G12A). A clinical description of his condition was recorded throughout his life, including cardiovascular diseases, endocrine disorders, and recurrent infections. At 20 months of age, after presenting events of marked hypotonia and generalized seizures, brain magnetic resonance revealed symmetrical lesions of the infra- and supratentorial white matter in both cerebral hemispheres, which resulted in the diagnosis of cerebral leukodystrophy. The patient had a rapid and progressive deterioration that eventually led to death.

Conclusions

This is the first report of a case of CS in Peru. In addition, this is a case that presented with multisystemic conditions culminating in leukodystrophy, which is a rare event according to the literature.
Literature
1.
go back to reference Costello J. A new syndrome. NZ Med J. 1971;74:397. Costello J. A new syndrome. NZ Med J. 1971;74:397.
2.
go back to reference Hernández EES, Chang VJT, Vigo OW, Zalazar OP. Síndrome Costello. Reporte de un caso. Medimay. 2017;24(1):79–86. Hernández EES, Chang VJT, Vigo OW, Zalazar OP. Síndrome Costello. Reporte de un caso. Medimay. 2017;24(1):79–86.
3.
go back to reference Choi N, Ko JM, Shin SH, Kim EK, Kim HS, Song MK, et al. Phenotypic and genetic characteristics of five korean patients with Costello Syndrome. Cytogenet Genome Res. 2019;158(4):184–91.CrossRefPubMed Choi N, Ko JM, Shin SH, Kim EK, Kim HS, Song MK, et al. Phenotypic and genetic characteristics of five korean patients with Costello Syndrome. Cytogenet Genome Res. 2019;158(4):184–91.CrossRefPubMed
4.
go back to reference Gripp KW, Morse LA, Axelrad M, Chatfield KC, Chidekel A, Dobyns W, et al. Costello syndrome: clinical phenotype, genotype, and management guidelines. Am J Med Genet A. 2019;179(9):1725–44.CrossRefPubMedPubMedCentral Gripp KW, Morse LA, Axelrad M, Chatfield KC, Chidekel A, Dobyns W, et al. Costello syndrome: clinical phenotype, genotype, and management guidelines. Am J Med Genet A. 2019;179(9):1725–44.CrossRefPubMedPubMedCentral
5.
go back to reference Vanderver A, Prust M, Tonduti D, Mochel F, Hussey HM, Helman G, et al. Case definition and classification of leukodystrophies and leukoencephalopathies. Mol Genet Metab. 2015;114(4):494–500.CrossRefPubMedPubMedCentral Vanderver A, Prust M, Tonduti D, Mochel F, Hussey HM, Helman G, et al. Case definition and classification of leukodystrophies and leukoencephalopathies. Mol Genet Metab. 2015;114(4):494–500.CrossRefPubMedPubMedCentral
7.
9.
go back to reference Gripp KW, Rauen KA, et al. Costello syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews®. Seattle (WA): University of Washington; 2019. Gripp KW, Rauen KA, et al. Costello syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews®. Seattle (WA): University of Washington; 2019.
10.
go back to reference Rodríguez YLD, Fernández MdLÁV. Síndrome de Costello. Presentación de un caso. Revista. 2020;59(276):872. Rodríguez YLD, Fernández MdLÁV. Síndrome de Costello. Presentación de un caso. Revista. 2020;59(276):872.
11.
go back to reference Gripp KW, Lin AE. Costello syndrome: a Ras/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations. Genet Med. 2012;14(3):285–92.CrossRefPubMed Gripp KW, Lin AE. Costello syndrome: a Ras/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations. Genet Med. 2012;14(3):285–92.CrossRefPubMed
12.
go back to reference Güvenç O, Şengül FS, Saygı M, Ergül Y, Güzeltaş A. Hypertrophic cardiomyopathy and Costello syndrome: review of recent related literature with case report. Turk Kardiyol Dern Ars. 2014;42(8):767–70.CrossRefPubMed Güvenç O, Şengül FS, Saygı M, Ergül Y, Güzeltaş A. Hypertrophic cardiomyopathy and Costello syndrome: review of recent related literature with case report. Turk Kardiyol Dern Ars. 2014;42(8):767–70.CrossRefPubMed
13.
go back to reference Hakim K, Boussaada R, Hamdi I, Msaad H. Cardiac events in Costello syndrome: one case and a review of the literature. J Saudi Heart Assoc. 2014;26(2):105–9.CrossRefPubMed Hakim K, Boussaada R, Hamdi I, Msaad H. Cardiac events in Costello syndrome: one case and a review of the literature. J Saudi Heart Assoc. 2014;26(2):105–9.CrossRefPubMed
15.
go back to reference Triantafyllou P, Christoforidis A, Vargiami E, Zafeiriou DI. Growth hormone replacement therapy in Costello syndrome. Growth Horm IGF Res. 2014;24(6):271–5.CrossRefPubMed Triantafyllou P, Christoforidis A, Vargiami E, Zafeiriou DI. Growth hormone replacement therapy in Costello syndrome. Growth Horm IGF Res. 2014;24(6):271–5.CrossRefPubMed
16.
go back to reference Ballesta Martínez M, Guillén-Navarro E. Síndrome de Noonan. Protoc Diagn Ter Pediatr. 2010;1:56–63. Ballesta Martínez M, Guillén-Navarro E. Síndrome de Noonan. Protoc Diagn Ter Pediatr. 2010;1:56–63.
17.
go back to reference Detweiler S, Thacker MM, Hopkins E, Conway L, Gripp KW. Orthopedic manifestations and implications for individuals with Costello syndrome. Am J Med Genet A. 2013;161(8):1940–9.CrossRef Detweiler S, Thacker MM, Hopkins E, Conway L, Gripp KW. Orthopedic manifestations and implications for individuals with Costello syndrome. Am J Med Genet A. 2013;161(8):1940–9.CrossRef
18.
go back to reference Morice-Picard F, Ezzedine K, Delrue MA, Arveiler B, Fergelot P, Taïeb A, et al. Cutaneous manifestations in Costello and cardiofaciocutaneous syndrome: report of 18 cases and literature review. Pediatr Dermatol. 2013;30(6):665–73.CrossRefPubMed Morice-Picard F, Ezzedine K, Delrue MA, Arveiler B, Fergelot P, Taïeb A, et al. Cutaneous manifestations in Costello and cardiofaciocutaneous syndrome: report of 18 cases and literature review. Pediatr Dermatol. 2013;30(6):665–73.CrossRefPubMed
19.
go back to reference Kratz C, Franke L, Peters H, Kohlschmidt N, Kazmierczak B, Finckh U, et al. Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes. Br J Cancer. 2015;112(8):1392–7.CrossRefPubMedPubMedCentral Kratz C, Franke L, Peters H, Kohlschmidt N, Kazmierczak B, Finckh U, et al. Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes. Br J Cancer. 2015;112(8):1392–7.CrossRefPubMedPubMedCentral
20.
go back to reference Shikany AR, Baker L, Stabley DL, Robbins K, Doyle D, Gripp KW, et al. Medically actionable comorbidities in adults with Costello syndrome. Am J Med Genet A. 2020;182(1):130–6.CrossRefPubMed Shikany AR, Baker L, Stabley DL, Robbins K, Doyle D, Gripp KW, et al. Medically actionable comorbidities in adults with Costello syndrome. Am J Med Genet A. 2020;182(1):130–6.CrossRefPubMed
Metadata
Title
Fatal leukodystrophy in Costello syndrome: a case report
Authors
Virgilio E. Failoc-Rojas
Piero A. Quiroz Ugaz
Dante A. Loconi León
Sandra Zeña-Ñañez
Publication date
01-12-2023
Publisher
BioMed Central
Keyword
Leukodystrophy
Published in
BMC Pediatrics / Issue 1/2023
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-023-04166-z

Other articles of this Issue 1/2023

BMC Pediatrics 1/2023 Go to the issue